Julien Alberici
Corporate Officer/Principal bij BAIKOWSKI
Profiel
Julien Alberici is the founder and Chief Executive Officer of Mathym SAS, a company founded in 2013.
He is currently the CEO of Octalfa SAS since 2013.
Additionally, he holds the position of Director-Business Development at Baikowski SA since 2019.
Mr. Alberici is also the founder of ORPHELIA Pharma SAS and currently serves as a Director.
Actieve functies van Julien Alberici
| Bedrijven | Functie | Begin |
|---|---|---|
| BAIKOWSKI | Corporate Officer/Principal | 01-10-2019 |
Octalfa SAS
 Octalfa SAS Investment ManagersFinance Octalfa SAS is a family-owned, independent private equity holding and investment company controlled by Gilles Alberici. Octalfa was established in 2006 and is based near Lyon in Eastern France. The firm manages a portfolio of participations in Life Sciences companies. They are also the key investor of Octalfa 360 Health and Green Technologies, a sector mutual fund invested in listed equity, co-managed by 360 Asset Managers SA and Xénia SARL (aka Xénia Gestion Privée). The fund focuses on sectors such as biotechnology and clean technology. Octalfa is committed to public health issues, and established the Dominique Alberici-Octalfa Corporate Foundation to support initiatives aimed at improving medical and paramedical care for cancer patients and the disabled. | Hoofd Administratief Officier | 01-01-2013 |
Mathym SAS
 Mathym SAS Miscellaneous Commercial ServicesCommercial Services Mathym SAS engages in the development, manufacture, and commercialization of colloidal solutions for biomedical applications. It specializes in nano-dispersions. The company was founded by Julien Alberici and Frederic Chaput in September 1, 2013 and is headquartered in Champagne-au-Mont-d'Or, France. | Algemeen Directeur | 01-09-2013 |
ORPHELIA Pharma SAS
 ORPHELIA Pharma SAS Pharmaceuticals: MajorHealth Technology ORPHELIA Pharma SA specializes on biopharmaceutical products improving the health and well being of severely disabled children. The company was founded by Hugues Bienaymé in 2007 and is headquartered in Paris, France. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BAIKOWSKI | Process Industries |
| Bedrijven in privébezit | 3 |
|---|---|
Octalfa SAS
Octalfa SAS Investment ManagersFinance Octalfa SAS is a family-owned, independent private equity holding and investment company controlled by Gilles Alberici. Octalfa was established in 2006 and is based near Lyon in Eastern France. The firm manages a portfolio of participations in Life Sciences companies. They are also the key investor of Octalfa 360 Health and Green Technologies, a sector mutual fund invested in listed equity, co-managed by 360 Asset Managers SA and Xénia SARL (aka Xénia Gestion Privée). The fund focuses on sectors such as biotechnology and clean technology. Octalfa is committed to public health issues, and established the Dominique Alberici-Octalfa Corporate Foundation to support initiatives aimed at improving medical and paramedical care for cancer patients and the disabled. | Finance |
Mathym SAS
Mathym SAS Miscellaneous Commercial ServicesCommercial Services Mathym SAS engages in the development, manufacture, and commercialization of colloidal solutions for biomedical applications. It specializes in nano-dispersions. The company was founded by Julien Alberici and Frederic Chaput in September 1, 2013 and is headquartered in Champagne-au-Mont-d'Or, France. | Commercial Services |
ORPHELIA Pharma SAS
ORPHELIA Pharma SAS Pharmaceuticals: MajorHealth Technology ORPHELIA Pharma SA specializes on biopharmaceutical products improving the health and well being of severely disabled children. The company was founded by Hugues Bienaymé in 2007 and is headquartered in Paris, France. | Health Technology |